Skip to main content
. 2017 Oct 16;7(10):e016857. doi: 10.1136/bmjopen-2017-016857

Table 4.

Summary of evidence from quantitative research syntheses

Intervention Number of systematic reviews/meta-analysis, total participants First author, year Primary results/findings Rating the evidence of effectiveness
Patients with acute coronary syndrome
General health education Six/161 997 patients (Goulding et al, 201051 did not give the total sample size) Ghisi, 201450 Knowledge 91% studies* Some evidence
Behaviour 77%/84%/65% studies*
Psychosocial indicators 43% studies*
Brown, 201337 Mortality
MI
Revascularisations
Hospitalisations
HRQoL
Withdrawals/dropouts
Healthcare utilisation and costs
Brown, 201170 Total mortality
MI
CABG
Hospitalisations
HRQoL 63.6% studies*
Healthcare costs 40% studies*
Withdrawal/dropout
Goulding, 201051 Beliefs 30.08% studies*
Secondary outcomes
Fernandez, 200748 Smoking
Cholesterol level
Multiple risk factor modification
Kotb, 201459 All-cause hospitalisation
All-cause mortality
Smoking cessation
Depression
Systolic blood pressure
Low-density lipoprotein
Anxiety
Psychoeducational interventions Six/37 883 patients Barth, 201569 Abstinence by self-report or validated Sufficient evidence
Dickens, 201345 Depression
Aldcroft, 201131 Smoking cessation
Physical activity
Huttunen-Lenz,201056 Prevalent smoking cessation
Continuous smoking cessation
Total mortality
Barth, 200836 Abstinence by self-report or validated
Smoking status
Barth, 200635 Abstinence
Smoking status
Secondary prevention educational interventions (including Internet-based secondary prevention) Three/25 154 patients Devi, 201544 Mortality Some evidence
Revascularisation
Total cholesterol
HDL cholesterol
Triglycerides
HRQOL
Auer, 200834 All-cause mortality
Readmission rates
Reinfarction rates
Smoking cessation rates
Clark, 200541 Mortality
MI
Quality of life Most of the included studies*
Patients with T2DM
General health education Five/2319 patients (Choi et al, 201640; Loveman et al, 200860; Zabaleta et al, 200779 did not give the total sample size) Choi, 201640 HbA1c Some evidence
Saffari, 201474 Glycaemic control
Duke, 200946 HbA1c
BP
Knowledge, psychosocial outcomes and smoking habits No data
Diabetes complications or health service utilisation and cost analysis No data
Loveman, 200860 Diabetic control outcomes 46.15% studies*
Weight 66.67% studies*
Cholesterol or triglycerides 40.00% studies (+)
Zabaleta, 200779 HbA1c 4.8% studies*
Culturally appropriate health education Eight/20 622 patients (Ricci-Cabello et al, 201473 and Gucciardi et al, 201352 did not give the total sample size) Creamer, 201642 HbA1c Some evidence
HRQoL
AEs No AEs
Ricci-Cabello, 201473 HbA1c
Diabetes knowledge 73.3% studies*
Behaviours 75% studies*
Clinical outcomes Fasting blood glucose, HbA1c and BP improved in 71%, 59% and 57% of the studies
Attridge, 201433 HbA1c
Knowledge scores
Clinical outcomes
Other outcome measures Showed neutral effects
Gucciardi, 201352 HbA1c levels 3 of 10 studies*
Anthropometrics 3 of 11 studies*
Physical activity One of five studies*
Diet outcomes Two of six studies*
Nam, 201262 HbA1c level
Hawthorne, 201054 HbA1c
Knowledge scores
Khunti, 200858 Knowledge levels Only one study reporting a significant improvement
Biomedical outcomes Only one study reporting a significant improvement
Hawthorne, 200853 HbA1c
Knowledge scores
Other outcome measures
Lifestyle interventions+behavioural programme Six/10 440 patients (Huang et al, 201655; Pillay et al, 201571 and Ramadas et al, 201177 did not give the total sample size) Huang, 201655 HbA1c Some evidence
BMI
LDL-c and HDL-c
Chen, 201539 HbA1c
BMI
SBP
DBP
HDL-c
Terranova, 201572 HbA1c level
Weight
Pillay, 201571 HbA1c levels
BMI
Ramadas, 201177 HbA1c 46.2% studies *
Gary, 200349 Fast blood sugar
Glycohaemoglobin
HbA1
HbA1c
Weight
Self-management educational interventions Nine/19 597 patients (Minet et al, 201061; Fan et al, 200947 and Norris et al, 200164 did not give the total sample size) Pal, 201467 Cardiovascular risk factors Sufficient evidence
Cognitive outcomes
Behavioural outcomes Only one study reporting a significant improvement
AEs No AEs
Vugt, 201375 Health behaviours 7 of 13 studies *
Clinical outcomes measures Nine studies *
Psychological outcomes Nine studies *
Pal, 201368 HbA1c
Depression
Quality of life
Weight
Steinsbekk, 201276 HbA1c
Main lifestyle outcomes
Main psychosocial outcomes
Minet, 201061 Glycaemic control
Fan, 200947 Diabetes knowledge
Overall self-management behaviours
Overall metabolic outcomes
Overall weighted mean effect sizes
Deakin, 200543 Metabolic control (HbA1c)
Fasting blood glucose levels
Weight
Diabetes knowledge
SBP
Diabetes medication
Norris, 200265 Total GHb
Norris, 200164 Knowledge
Self-monitoring of blood glucose
Self-reported dietary habits
Glycaemic control
Therapeutic education One/total sample: unclear Odnoletkova, 201466 Cost-effectiveness Overall high in studies on prediabetes and varied in studies on T2DM Insufficient evidence
Foot health education One/total sample: unclear Amaeshi32 Diabetes complications Some evidence
Incidence of LEA
Group medical visit One/2240 patients Burke, 201138 HbA1c Some evidence
BP and DBP
SBP
Cholesterol—LDL
Psychoeducational intervention One/1431 patients Alam, 200930 HbA1c Some evidence
Psychological status
Interventions aimed at improving adherence to medical treatment recommendations Three/4907 patients (Lun Gan et al, 201157 did not give the total sample size) Lun Gan, 201157 Oral hypoglycaemic adherence Five of seven studies * Some evidence
Wens et al., 200878 Adherence General conclusions could not be drawn
Vermeire, 200580 HbA1c
Dietary advice One/1467 patients Nield, 200763 Glycaemic control (addition of exercise to dietary advice) Insufficient evidence to determine
Weight Limited data
Diabetic microvascular and macrovascular diseases Limited data

*Intervention group is significantly better than control group, for example, ‘91% studies ’ means 91% studies reported a significant better compared with control group.

AEs, adverse events; BMI, body mass index; BP, blood pessure; CABG, coronary artery bypass graft surgery; HbA1c, glycated haemoglobin; HRQoL, health related quality of life; LDL-c, low-density lipoprotein cholesterol; LEA, lower extremity amputation; MI, myocardial infarction; RCTs, randomised controlled trials; SBP, systolic blood pressure, DBP, diastolic blood pressure, HDL-c, high density lipoprotein cholesterol; T2DM, type two diabetes mellitus.